Literature DB >> 15616241

Is atherosclerosis in diabetes and impaired fasting glucose driven by elevated LDL cholesterol or by decreased HDL cholesterol?

Heinz Drexel1, Stefan Aczel, Thomas Marte, Werner Benzer, Peter Langer, Willi Moll, Christoph H Saely.   

Abstract

OBJECTIVE: To evaluate the atherogenicity of lipids in coronary patients with normal fasting glucose (NFG), impaired fasting glucose (IFG), and type 2 diabetes. RESEARCH DESIGN AND METHODS: Serum lipid values, the presence of angiographic coronary artery disease (CAD) at baseline, and the incidence of vascular events over 2.3 years were recorded in 750 consecutive patients undergoing coronary angiography.
RESULTS: Triglycerides significantly (P < 0.001) increased and HDL cholesterol (P < 0.001) as well as LDL particle diameter (P < 0.001) significantly decreased from subjects with NFG <5.6 mmol/l (n = 272) over patients with IFG > or =5.6 mmol/l (n = 314) to patients with type 2 diabetes (n = 164). Factor analysis revealed two factors in the lipid profiles of our patients: triglycerides, HDL cholesterol, apolipoprotein A1, and LDL particle diameter loaded high on an HDL-related factor, and total cholesterol, LDL cholesterol, and apolipoprotein B loaded high on an LDL-related factor. In patients with type 2 diabetes, the HDL-related factor (odds ratio 0.648 [95% CI 0.464-0.904]; P = 0.011), but not the LDL-related factor (0.921 [0.677-1.251]; P = 0.597), was associated with significant coronary stenoses > or =50%. Consistently, in the prospective study, the HDL-related factor (0.708 [0.506-0.990]; P = 0.044), but not the LDL-related factor (1.362 [0.985-1.883]; P = 0.061), proved significantly predictive for vascular events in patients with type 2 diabetes.
CONCLUSIONS: The low HDL cholesterol/high triglyceride pattern is associated with the degree of hyperglycemia. In coronary patients with type 2 diabetes, this pattern correlates with the prevalence of CAD and significantly predicts the incidence of vascular events.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15616241     DOI: 10.2337/diacare.28.1.101

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  41 in total

Review 1.  The emerging role of HDL in glucose metabolism.

Authors:  Brian G Drew; Kerry-Anne Rye; Stephen J Duffy; Philip Barter; Bronwyn A Kingwell
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

2.  Triglyceride to HDL-C ratio and increased arterial stiffness in apparently healthy individuals.

Authors:  Jiang-Hua Wen; Yu-Yu Zhong; Zhi-Gang Wen; Chao-Qun Kuang; Jie-Rong Liao; Li-Hua Chen; Pei-Shen Wang; Yue-Xia Wu; Chu-Jun Ouyang; Zhi-Jin Chen
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 3.  Lipid lowering therapy in type 2 diabetes.

Authors:  Bernhard Föger
Journal:  Wien Med Wochenschr       Date:  2011-06

4.  Reconstituted high-density lipoprotein infusion modulates fatty acid metabolism in patients with type 2 diabetes mellitus.

Authors:  Brian G Drew; Andrew L Carey; Alaina K Natoli; Melissa F Formosa; Donna Vizi; Medini Reddy-Luthmoodoo; Jacquelyn M Weir; Christopher K Barlow; Gerrit van Hall; Peter J Meikle; Stephen J Duffy; Bronwyn A Kingwell
Journal:  J Lipid Res       Date:  2011-01-11       Impact factor: 5.922

5.  NASH resolution is associated with improvements in HDL and triglyceride levels but not improvement in LDL or non-HDL-C levels.

Authors:  K E Corey; R Vuppalanchi; L A Wilson; O W Cummings; N Chalasani
Journal:  Aliment Pharmacol Ther       Date:  2014-11-28       Impact factor: 8.171

6.  Non-albuminuric renal impairment is a strong predictor of mortality in individuals with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicentre study.

Authors:  Giuseppe Penno; Anna Solini; Emanuela Orsi; Enzo Bonora; Cecilia Fondelli; Roberto Trevisan; Monica Vedovato; Franco Cavalot; Olga Lamacchia; Marco Scardapane; Antonio Nicolucci; Giuseppe Pugliese
Journal:  Diabetologia       Date:  2018-07-21       Impact factor: 10.122

7.  Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs.

Authors:  Xuefen Xie; Hailing Liao; Huaixin Dang; Wei Pang; Youfei Guan; Xian Wang; John Y-J Shyy; Yi Zhu; Frances M Sladek
Journal:  Mol Endocrinol       Date:  2009-01-29

8.  Low bone mineral density is not associated with angiographically determined coronary atherosclerosis in men.

Authors:  S Beer; C H Saely; G Hoefle; P Rein; A Vonbank; J Breuss; B Gaensbacher; A Muendlein; H Drexel
Journal:  Osteoporos Int       Date:  2009-11-21       Impact factor: 4.507

9.  Management of risk factors for accelerated atherosclerosis.

Authors:  Sarah Song; Bruce Ovbiagele
Journal:  Curr Treat Options Neurol       Date:  2009-11       Impact factor: 3.598

10.  Baseline very low-density lipoprotein cholesterol is associated with the magnitude of triglyceride lowering on statins, fenofibric acid, or their combination in patients with mixed dyslipidemia.

Authors:  Abhinav Sharma; Parag H Joshi; Sarah Rinehart; Kamlesh M Thakker; Aditya Lele; Szilard Voros
Journal:  J Cardiovasc Transl Res       Date:  2014-04-11       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.